ABCB1 and osteosarcoma: Growing evidence showed that the increased risk of adverse events during treatment in some types of cancers, including acute myeloid leukemia (AML), ovarian cancer, osteosarcomas, and melanoma, is closely related to the high expression of ABCB1 [19,50,51,52,53,54].